01:14 PM, 30th Jun 2025
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2025 and signing of Unaudited Financial Results submission to the Stock Exchange and its Publication.